Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Cash & Current Investments (2017 - 2025)

Inspire Medical Systems' Cash & Current Investments history spans 9 years, with the latest figure at $308.3 million for Q4 2025.

  • For Q4 2025, Cash & Current Investments fell 30.81% year-over-year to $308.3 million; the TTM value through Dec 2025 reached $308.3 million, down 30.81%, while the annual FY2025 figure was $308.3 million, 30.81% down from the prior year.
  • Cash & Current Investments for Q4 2025 was $308.3 million at Inspire Medical Systems, down from $322.6 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $467.1 million in Q2 2023 and bottomed at $196.3 million in Q2 2022.
  • The 5-year median for Cash & Current Investments is $390.1 million (2024), against an average of $351.0 million.
  • The largest annual shift saw Cash & Current Investments skyrocketed 137.9% in 2023 before it crashed 31.56% in 2025.
  • A 5-year view of Cash & Current Investments shows it stood at $214.5 million in 2021, then soared by 110.48% to $451.4 million in 2022, then increased by 1.99% to $460.4 million in 2023, then fell by 3.22% to $445.5 million in 2024, then plummeted by 30.81% to $308.3 million in 2025.
  • Per Business Quant, the three most recent readings for INSP's Cash & Current Investments are $308.3 million (Q4 2025), $322.6 million (Q3 2025), and $300.9 million (Q2 2025).